Switch to:
AbbVie Inc (NYSE:ABBV)
Cash Flow for Capital Expenditures
$-540 Mil (TTM As of Mar. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

AbbVie Inc's cash flow for capital expenditures for the three months ended in Mar. 2014 was $-137 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2014 was $-540 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

AbbVie Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Mar. 2014 was -119 (Jun. 2013 ) + -133 (Sep. 2013 ) + -151 (Dec. 2013 ) + -137 (Mar. 2014 ) = $-540 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

AbbVie Inc Annual Data

Dec09Dec10Dec11Dec12Dec13
Cash Flow_CPEX 00000-313-448-356-333-491

AbbVie Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Cash Flow_CPEX -105-162-9418-95-88-119-133-151-137
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide